Saturday, 31 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Legal & Regulatory

Colinz Laboratories Legal & Regulatory

Colinz Laboratories Ltd states related party transaction disclosures are exempt for Q2 2026 under SEBI LODR 23(9). The filing complies with exemption under Regulation 15(2)(a).

Source

BSE filing, NSE: COLINZ. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Colinz Laboratories Ltd: key numbers

Share price
₹69.25
Market cap
₹17.44 Cr
Revenue (annual)
₹6.14 Cr
Net profit (annual)
₹0.51 Cr
P/E (TTM)
6.3×Sector 45.9×
Promoter holding
50.60%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Colinz Laboratories Ltd

All →

Other legal & regulatory announcements

All →